Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)NCT03846219Immunic AGPhase 2Active not recruiting2020-04-24Actual
QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint TherapyNCT03853317IBRXPhase 2Terminated2021-09-29Actual
Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007NCT03853798AGIOPhase 3Completed2024-07-03Actual
Clinical Study Comparing Two Models of a Travoprost Intraocular ImplantNCT03868124Glaukos CorporationPhase 3Completed2022-06-10Actual
Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE Attacks in JapanNCT03873116BioCryst PharmaceuticalsPhase 3Completed2021-07-08Actual
VELOCITY: An Anthrax Vaccine Clinical StudyNCT03877926Emergent BioSolutionsPhase 3Completed2020-08-06Actual
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian CancerNCT03878849Allarity TherapeuticsPhase 2Recruiting2027-03Estimated
The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye DiseaseNCT03879863ALDXPhase 3Completed2019-10-04Actual
Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)NCT03881852AXSMPhase 2Completed2019-11-27Actual
RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical CancerNCT03894215AGENPhase 2Terminated2025-03-26Actual
Maximizing Outcomes in Treating Acute MigraineNCT03896009AXSMPhase 3Completed2019-12-10Actual
A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic CancerNCT03899636ANGOPhase 3Active not recruiting2025-04Estimated
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and FibrosisNCT03900429MDGLPhase 3Active not recruiting2028-01Estimated
IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell LymphomaNCT03902184Innate PharmaPhase 2Completed2026-01-08Actual
PRO 140 in Treatment-Experienced HIV-1 SubjectsNCT03902522CytoDyn, Inc.Phase 2, Phase 3Completed2020-05-18Actual
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)NCT03905330MIRMPhase 3Completed2022-09-01Actual
A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye DiseaseNCT03916042ALDXPhase 2Completed2019-11-22Actual
Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia CongenitaNCT03920228PVLAPhase 2, Phase 3Completed2020-09-19Actual
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular AtrophyNCT03921528Scholar Rock, Inc.Phase 2Completed2021-01-19Actual
Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial SpondyloarthritisNCT03926195LKFTPhase 2Completed2020-08-14Actual
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerNCT03929666Jazz PharmaceuticalsPhase 2Completed2025-08-30Actual
APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell TransplantNCT03931291Aprea TherapeuticsPhase 2Completed2021-08-27Actual
Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell CarcinomaNCT03937219ExelixisPhase 3Active not recruiting2022-01-31Actual
Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)NCT03938246SGMTPhase 2Completed2021-10-02Actual
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)NCT03940196NVCRPhase 3Completed2023-05-18Actual
Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic CancerNCT03941093Kyntra BioPhase 3Completed2024-06-11Actual
Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)NCT03945292Arrowhead PharmaceuticalsPhase 2Completed2021-11-08Actual
Study of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD)NCT03946449Arrowhead PharmaceuticalsPhase 2Completed2022-04-28Actual
Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)NCT03955146Kyntra BioPhase 3Terminated2023-03-20Actual
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital WartsNCT03981822VRCAPhase 2Completed2020-05-21Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.